Angiotensin-Converting Enzyme nhibition Prevents Glomerular-Tubule Disconnection and Atrophy in Passive Heymann Nephritis, an Effect Not Observed with a Calcium Antagonist-Reference-Cited by-同舟云学术

Angiotensin-Converting Enzyme nhibition Prevents Glomerular-Tubule Disconnection and Atrophy in Passive Heymann Nephritis, an Effect Not Observed with a Calcium Antagonist

Published:2001-11 Issue:5 Volume:159 Page:1743-1750
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Benigni Ariela,Gagliardini Elena,Remuzzi Andrea,Corna Daniela,Remuzzi Giuseppe

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference33 articles.

1. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation;Hostetter;Am J Physiol,1981

2. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass;Anderson;J Clin Invest,1985

3. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease;Brenner;N Engl J Med,1982

4. Contribution of tubular injury to loss of remnant kidney function;Gandhi;Kidney Int,1998

5. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation;Abbate;J Am Soc Nephrol,1998

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Protein Exposure Activates a Core Regulatory Program Driving Human Proximal Tubule Injury;Journal of the American Society of Nephrology;2022-05

2. Autoimmune-mediated renal disease and hypertension;Clinical Science;2021-09

3. Multi-omic Characterization of Human Tubular Epithelial Cell Response to Serum;2021-01-29

4. Proteinuria and Tubulotoxicity;Diabetic Nephropathy;2018-10-30

5. Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression;European Journal of Pharmacology;2017-11